Susan Hasty, Publisher
Table of Contents . . . September 12th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Chronic Myeloid Leukemia - RNA interference silences cancer genes in leukemia cells
Retinopathy - Inducible system could be used for controlling protein therapies in the eye
Brain Injury - Gene construct reduces inflammatory reaction in traumatically injured brains
Cancer Therapy - Researchers identify potent angiogenesis inhibitor
Kidney Cancer - Tumor suppressor protein p27Kip1 arrests development in renal cell carcinoma
Asthma - Oxagen announces target validation collaboration with Pfizer
Breast Cancer Pathogenesis - Study identifies upregulated enzyme in invasive breast cancers
Cancer Therapy - Researchers aim to reduce side effects of retinoic acid
DNA Research - NimbleGen launches new custom DNA array service
Drug Development - NeoGenesis, Massachusetts General sign collaboration agreement
Finance - Net income reported at $0.17 per share
Grant Funding - Morphotek receives Army grant
Head and Neck Cancer - Regulatory filing completed in Europe for Advexin gene drug
Human Papillomavirus - New patent granted related to methods for assessment of HPV-induced disease
Myocardial Ischemia - New gene delivery method restores myocardial function
Patent Litigation - Orchid settles with Saint Louis University, acquires primer extension patent
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.